ACE2 downregulation is associated with poor prognosis in SARS and COVID-19 patients, by exacerbating ARDS [111,112,113], severe pneumonia [110,112], and extra-pulmonary conditions including acute kidney injury and cardiac injury [111,112]. This evidence concerns the gene ACE2 and COVID-19.